| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2013 | WO2013044811A1 Gemcitabine amide derivative and preparation method and use thereof |
| 04/04/2013 | WO2013044793A1 High-purity heparin benzyl ester salt, preparation method therefor and application thereof |
| 04/04/2013 | WO2013044788A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044763A1 3-fluoro-5-(trifluoromethyl)-n-(2-(2-thienyl)ethyl)benzamide and use thereof |
| 04/04/2013 | WO2013044736A1 Traditional chinese medicine composition for external use in treating xerophthalmia and the preparation method thereof |
| 04/04/2013 | WO2013044608A1 Anomeric alkyl-containing phenyl c-glucoside derivative, preparation method therefor and use thereof |
| 04/04/2013 | WO2013044596A1 Kidney-type glutaminase inhibitor and preparation method and use thereof |
| 04/04/2013 | WO2013044511A1 Pharmaceutical composition containing riligustilide and use thereof |
| 04/04/2013 | WO2013044362A1 Selected inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044361A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044360A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044356A1 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 04/04/2013 | WO2013033155A8 Methods and compositions for reducing serum levels of immunoglobulin e (ige) |
| 04/04/2013 | WO2013023015A3 Targets for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes |
| 04/04/2013 | WO2013021389A8 Downregulation of mir-7 for promotion of beta cell differentiation and insulin production |
| 04/04/2013 | WO2013019901A3 Tropinol esters and related compounds to promote normal processing of app |
| 04/04/2013 | WO2013019711A3 NOVEL 17β-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS |
| 04/04/2013 | WO2013019620A3 Method of treating cancer using combination of braf inhibitor, mek inhibitor, and anti-ctla-4 antibody |
| 04/04/2013 | WO2013019058A3 Pharmaceutical composition for inhibiting cancer recurrence or metastasis |
| 04/04/2013 | WO2013018091A8 Particles for the treatment of neurodegenerative diseases |
| 04/04/2013 | WO2013017910A8 Extended release pharmaceutical compositions containing paliperidone |
| 04/04/2013 | WO2013015634A3 Pharmaceutical composition for treating atopic dermatitis |
| 04/04/2013 | WO2013014204A3 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 04/04/2013 | WO2013007361A8 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 04/04/2013 | WO2013003583A3 Somatic mutations in atrx in brain cancer |
| 04/04/2013 | WO2012178127A3 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
| 04/04/2013 | WO2012177844A3 Substituted imidazopyridinyl-aminopyridine compounds |
| 04/04/2013 | WO2012177100A3 Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent |
| 04/04/2013 | WO2012174555A3 Composition and method for stabilization and delivery of therapeutic molecules |
| 04/04/2013 | WO2012174035A3 A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine |
| 04/04/2013 | WO2012174013A3 Treatment of cardiovascular disease, stroke, and inflammatory conditions |
| 04/04/2013 | WO2012173987A3 Methods of treatment using a bcat1 inhibitor |
| 04/04/2013 | WO2012173689A3 Antimicrobial compounds and methods of making and using the same |
| 04/04/2013 | WO2012173447A3 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient |
| 04/04/2013 | WO2012171024A3 Enzyme directed assembly of particle theranostics |
| 04/04/2013 | WO2012170917A3 Reduction of microglia-mediated neurotoxicity by kv1.3 inhibition |
| 04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
| 04/04/2013 | WO2012154756A9 Delaying the progression of diabetes |
| 04/04/2013 | WO2012142575A3 Monomeric trioxane amide sulfur compounds |
| 04/04/2013 | WO2012142313A3 Micro-rna inhibitors and their uses in disease |
| 04/04/2013 | WO2012137982A3 Sulfonamide derivative and use thereof |
| 04/04/2013 | WO2012135498A3 Nutritional supplement comprising nut and seed oil composition |
| 04/04/2013 | WO2012128799A3 Treating schizophrenia |
| 04/04/2013 | WO2012118712A3 Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection |
| 04/04/2013 | WO2012074856A3 Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
| 04/04/2013 | WO2012072713A3 Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae |
| 04/04/2013 | WO2012071212A3 Novel phosphonic acids as s1p receptor modulators |
| 04/04/2013 | WO2011139246A4 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases |
| 04/04/2013 | WO2011068872A8 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 04/04/2013 | WO2010131116A3 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 04/04/2013 | WO2009061730A3 4 -heteroaryl- substituted phenoxyphenylacetic acid derivatives as pgd2 inhibitors |
| 04/04/2013 | US20130085469 Taurolidine formulations and delivery: therapeutic treatments and antimicrobial protection against bacterial biofilm formation |
| 04/04/2013 | US20130085461 Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof |
| 04/04/2013 | US20130085184 Intrathecal or Epidural Administration of 3-[(1S,2S)-3-(Dimethylamino)-1-Ethyl-2-Methylpropyl]Phenol |
| 04/04/2013 | US20130085181 Pharmaceutical formulations |
| 04/04/2013 | US20130085180 Oral bioavailable pentamidin prodrugs for treatment of diseases |
| 04/04/2013 | US20130085179 Methods of therapeutic monitoring of nitrogen scavenging drugs |
| 04/04/2013 | US20130085178 Composition for treating bone disease comprising a glyceollin as an active ingredient |
| 04/04/2013 | US20130085176 Process for the preparation of sulfamide derivatives |
| 04/04/2013 | US20130085175 Process for the preparation of sulfamide derivatives |
| 04/04/2013 | US20130085174 Acne treatment |
| 04/04/2013 | US20130085172 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | US20130085171 Compounded transdermal pain management |
| 04/04/2013 | US20130085170 Compositions comprising amino acids, with pro-angiogenic activity |
| 04/04/2013 | US20130085169 Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
| 04/04/2013 | US20130085167 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 04/04/2013 | US20130085166 Formulations and uses of retinoic acid receptor selective agonists |
| 04/04/2013 | US20130085164 Imidazole Derivatives |
| 04/04/2013 | US20130085162 AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 04/04/2013 | US20130085161 Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/04/2013 | US20130085159 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 04/04/2013 | US20130085158 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 04/04/2013 | US20130085157 Arylsubstituted thiazolotriazoles and thiazoloimidazoles |
| 04/04/2013 | US20130085155 Thiazolopyridine sirtuin modulating compounds |
| 04/04/2013 | US20130085153 Combination of an iap inhibitor and a taxane for the treatment of a proliferative disease |
| 04/04/2013 | US20130085152 Method For Assay On The Effect Of Vascularization Inhibitor |
| 04/04/2013 | US20130085150 Analogues for the treatment or prevention of flavivirus infections |
| 04/04/2013 | US20130085149 Osmolyte-containing preparation for the treatment of dry mucous membranes |
| 04/04/2013 | US20130085148 Pyridine Derivatives |
| 04/04/2013 | US20130085146 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues |
| 04/04/2013 | US20130085145 Imatinib mesilate pharmaceutical tablet |
| 04/04/2013 | US20130085144 Derivatives of azaindazole or diazaindazole type as medicament |
| 04/04/2013 | US20130085139 Oligomers |
| 04/04/2013 | US20130085138 Selective NR2B Antagonists |
| 04/04/2013 | US20130085137 Topical antimicrobial compositions and methods of using same |
| 04/04/2013 | US20130085130 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | US20130085129 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | US20130085124 Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation |
| 04/04/2013 | US20130085123 Organic compounds |
| 04/04/2013 | US20130085122 Baclofen and acamprosate based therapy of neurological disorders |
| 04/04/2013 | US20130085121 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 04/04/2013 | US20130085119 Agent for the treatment of skin conditions |
| 04/04/2013 | US20130085118 Method and mixture for treating and preventing inflammatory bowel disease |
| 04/04/2013 | US20130085116 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof |
| 04/04/2013 | US20130085115 Combination therapy for lymphoma |
| 04/04/2013 | US20130085114 Method for treating varicocele or male infertility using anthocyanin extracted from black soybean |
| 04/04/2013 | US20130085109 Methods of cardiovascular patient treatment using substances sufficient to reduce actin depolymerization |
| 04/04/2013 | US20130085103 Novel synergistic pharmaceutical composition for topical applications |
| 04/04/2013 | US20130085102 Prevention of hypoglycemia in diabetes mellitus type 2 patients |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |